AbbVie Ads

At ABS, we are proud to recognize 𝗪𝗼𝗿𝗹𝗱 𝗢𝘃𝗮𝗿𝗶𝗮𝗻 𝗖𝗮𝗻𝗰𝗲𝗿 𝗗𝗮𝘆 and to support greater awareness of ovarian cancer worldwide. Behind every statistic is a woman, a family, and a story of resilience. Today is a moment to reflect on the importance of listening, acting earlier, and working toward a future where progress in ovarian cancer reaches every woman who needs it.   #NoWomanLeftBehind #WorldOvarianCancerDay #WeAreAbbVie

Driven by Science, United by Purpose: Join Our Oncology Team.

The conversation doesn’t end at ASCO. At AbbVie, we’re looking for expert minds ready to take on tough challenges in oncology. Join a team where curiosity and collaboration drive innovation for patients. Together, we can explore the world of science.

Entries Now Open Through August 3

Know someone with #migraine? Share the AbbVie Migraine Career Catalyst Award™ contest with them for a chance to win up to $2,500 for financial support.

At ABS, we are proud to recognize 𝗪𝗼𝗿𝗹𝗱 𝗢𝘃𝗮𝗿𝗶𝗮𝗻 𝗖𝗮𝗻𝗰𝗲𝗿 𝗗𝗮𝘆 and to support greater awareness of ovarian cancer worldwide. Behind every statistic is a woman, a family, and a story of resilience. Today is a moment to reflect on the importance of listening, acting earlier, and working toward a future where progress in ovarian cancer reaches every woman who needs it.   #NoWomanLeftBehind #WorldOvarianCancerDay #WeAreAbbVie

See How Our Approach to Personalized IBD Care Aims to Improve Outcomes

Many patients with IBD still face gaps in disease control. Our researchers are using new insights in biology and real-world data to help advance care.

Katso tallenne ja opi tunnissa tärkein migreenistä työelämässä!

Näkymätön työkykyhaaste – mitä työnantajien tulisi ymmärtää migreenistä? Arviolta 850 000 suomalaista sairastaa migreeniä. Sairastavien hyvinvointia voisi parantaa pienillä, mutta ratkaisevilla teoilla.

Katso tallenne ja opi tunnissa tärkein migreenistä työelämässä!

Näkymätön työkykyhaaste – mitä työnantajien tulisi ymmärtää migreenistä? Arviolta 850 000 suomalaista sairastaa migreeniä. Sairastavien hyvinvointia voisi parantaa pienillä, mutta ratkaisevilla teoilla.

Why Disease Control Matters in PsA and axSpA

For HCPs managing PsA and axSpA, timing matters. Early recognition of non-response and timely intervention is associated with clinically meaningful improvements in patients’ daily lives. Understanding the whole patient is at the center of what we do. Learn more about AbbVie’s commitment to rheumatology.

IBD care is entering an exciting new phase as we saw from the recent DDW Congress. While inflammation remains central, there’s growing recognition that better outcomes may come from looking more broadly at the biology behind disease. Researchers are continuing to explore new ways to better understand Crohn’s disease and ulcerative colitis, including combination approaches and emerging targets that may help shape the future of treatment. Encouraging progress, but still more to learn — and more to do for patients living with IBD. Read the full essay to learn more: https://lnkd.in/gKeSAsEE #IBD #CrohnsDisease #UlcerativeColitis #Gastroenterology #Science #Innovation #Research

Explore our Accounting & Finance Program at NABA.

Meet us at NABA to explore our Accounting & Finance Development Program. Speak with our team to find out what’s possible.

Why Disease Control Matters in PsA and axSpA

For HCPs managing PsA and axSpA, timing matters. Early recognition of non-response and timely intervention is associated with clinically meaningful improvements in patients’ daily lives. Understanding the whole patient is at the center of what we do. Learn more about AbbVie’s commitment to rheumatology.

Entries Now Open Through August 3

Know someone with #migraine? Share the AbbVie Migraine Career Catalyst Award™ contest with them for a chance to win up to $2,500 for financial support.

Com a nova Lei da Pesquisa Clínica, o Brasil dá um passo importante para ampliar previsibilidade regulatória, atrair investimentos e fortalecer sua posição no cenário global de inovação.   Como médico, fico especialmente animado ao ver diferentes indústrias se mobilizando para apoiar esse avanço. Na AbbVie, recentemente anunciamos uma projeção de investimento de R$ 430 milhões em pesquisas locais até 2030, com o objetivo de contribuir também para a descentralização dos estudos para além do eixo Sul-Sudeste.   Neste artigo, compartilho minha visão sobre como o país pode acelerar sua agenda de inovação em saúde e gerar melhores desfechos para os pacientes.   Convido todos a ler o conteúdo e a compartilhar sua opinião nos comentários.

The Patient Burden of PsA and axSpA

In PsA and axSpA, complex manifestations can worsen disease activity and quality of life. Understanding the whole patient is at the center of what we do. Learn more about AbbVie’s commitment to rheumatology.

Explore our Accounting & Finance Program at NABA.

Meet us at NABA to explore our Accounting & Finance Development Program. Speak with our team to find out what’s possible.

今週、私たちは東京で年次記者会見を開催し、アッヴィの2025年における力強い業績をご報告しました。また、開発本部長の藤野忠弘より、拡充しつづけるアッヴィのパイプラインの紹介と、ワクワクするような将来の可能性について説明をしました。これまでの歩みを振り返りながら、2029年の目標に向けて着実に前進していることを共有できた、非常に意義深い機会となりました。 特に印象的だったのは、業績そのものだけでなく、その背景にある力強い勢いです。私たちのチームを前へと導いているのは、集中力、協働、そして共通の目的意識にほかなりません。透明性の向上、職場文化の強化、そして日本のイノベーション・エコシステムへの有意義な貢献を進められていることを、私たちは誇りに思っています。 また、日本におけるドラッグ・ラグ／ドラッグ・ロスという重要な課題についても触れ、イノベーション、パートナーシップ、そして拡大を続けるパイプラインを通じて、アンメットニーズの解決に貢献していくというアッヴィのコミットメントを改めてお伝えしました。これまでに築いてきた成果、そして日本の患者さんのために私たちが共に実現できる可能性に、大きな手応えを感じています。 この歩みを支えてくれているすべての社員に、心から感謝します。私たちはこれからも力を合わせて勢いを生み出し、日本の皆さまに長期的な価値をお届けしながら、Beyond the Best の実現に向けて前進していきます。 This week, we hosted our annual press conference in Tokyo and shared AbbVie’s strong 2025 performance. Together with Tad Fujino, M.D., Ph.D. , Head of Japan Development, we also introduced AbbVie’s expanding pipeline and explained the exciting possibilities ahead. It was a meaningful moment to reflect on how far we’ve come and the steady progress we are making toward our 2029 ambitions. 　 What stood out most to me was not only the business results, but the momentum behind them — the focus, collaboration, and shared purpose that continue to drive our teams forward. We are proud to be advancing transparency, strengthening our workplace culture, and contributing to Japan’s innovation ecosystem in meaningful ways. We also highlighted the important challenge of drug lag and drug loss in Japan, and AbbVie’s commitment to helping address unmet needs through innovation, partnerships, and a growing pipeline. It is encouraging to see how far we have come — and how much more we can achieve together for patients in Japan. I’m deeply grateful to all our employees in helping shape this journey. Together, we are building momentum, creating long-term value for the people of Japan, and moving steadily toward our Beyond the Best goals. #abbvie #press conference #innovation ecosystem #記者会見 #イノベーション・エコシステム

Enter by August 3 to Win $2,500

Navigating work with #migraine? Enter the AbbVie Migraine Career Catalyst Award™ contest for a chance to win up to $2,500 for financial support.

Enter by August 3 to Win $2,500

Navigating work with #migraine? Enter the AbbVie Migraine Career Catalyst Award™ contest for a chance to win up to $2,500 for financial support.

Hei %FIRSTNAME%,Työkyvyn tukeminen ja hyvinvointi ovat tällä hetkellä monessa organisaatiossa keskeisiä HR-teemoja. Yksi yleisimmistä työkykyyn ja hyvinvointiin vaikuttavista sairauksista jää kuitenkin edelleen usein tunnistamatta työelämässä: migreeni.Tässä kaksi tutkimukseen perustuvaa faktaa, joita ei voi ohittaa:Olet lämpimästi tervetullut maksuttomaan webinaariin: “Näkymätön työkykyhaaste – mitä työnantajien tulisi ymmärtää migreenistä?” 29.5. klo 10-11.Webinaarissa migreenin, työterveyden ja työkyvyn asiantuntijat tarkastelevat aihetta työelämän näkökulmasta:Tutustu ohjelmaan ja ilmoittaudu webinaariin täällä https://otamigreenivakavasti.fi/migreeni-vaikuttaa-merkittavasti-tyohyvinvointiin/.Lähetämme osallistumislinkin ilmoittautuneille lähempänä tapahtumaa.Ystävällisin terveisin,Nina CollianderExternal Affairs ManagerAbbVie Oy

The Patient Burden of PsA and axSpA

In PsA and axSpA, complex manifestations can worsen disease activity and quality of life. Understanding the whole patient is at the center of what we do. Learn more about AbbVie’s commitment to rheumatology.

𝗪𝗵𝗮𝘁 𝘆𝗼𝘂 𝘀𝗲𝗲 𝗶𝘀𝗻’𝘁 𝗮𝗹𝘄𝗮𝘆𝘀 𝘄𝗵𝗮𝘁 𝘆𝗼𝘂 𝗴𝗲𝘁. 💜 Today, 19 May, is World 𝗜𝗕𝗗 𝗗𝗮𝘆. Inflammatory Bowel Disease, which includes Crohn’s disease and ulcerative colitis, affects around 10 million people worldwide. It flares and quiets, and even when symptoms ease, inflammation can still be present underneath. That is what makes it easy to dismiss, and easy to delay acting on. So a simple message today. If your body has been telling you something, whether it is persistent abdominal pain, changes in your gut, or fatigue that doesn’t lift, listen to it.  Book the check-up.  Ask the question.  Whether it turns out to be IBD or something else entirely, knowing is always better than wondering. 𝘊𝘢𝘵𝘤𝘩𝘪𝘯𝘨 𝘵𝘩𝘪𝘯𝘨𝘴 𝘦𝘢𝘳𝘭𝘺 𝘪𝘴 𝘬𝘪𝘯𝘥𝘦𝘳 𝘵𝘩𝘢𝘯 𝘤𝘢𝘵𝘤𝘩𝘪𝘯𝘨 𝘵𝘩𝘦𝘮 𝘭𝘢𝘵𝘦. And if today is the first time you’re hearing about IBD, the kindest thing you can do is pass this on. Someone in your network may have been waiting for a reason to make that call. Special thanks to Mira Manck for sharing the image. I was looking around for something that fit today, and this one landed exactly right. 🥑💜 #WorldIBDDay2026 #IBDAwareness #WeAreAbbVie

Katso tallenne ja opi tunnissa tärkein migreenistä työelämässä!

Näkymätön työkykyhaaste – mitä työnantajien tulisi ymmärtää migreenistä? Arviolta 850 000 suomalaista sairastaa migreeniä. Sairastavien hyvinvointia voisi parantaa pienillä, mutta ratkaisevilla teoilla.

𝗪𝗵𝗮𝘁 𝘆𝗼𝘂 𝘀𝗲𝗲 𝗶𝘀𝗻’𝘁 𝗮𝗹𝘄𝗮𝘆𝘀 𝘄𝗵𝗮𝘁 𝘆𝗼𝘂 𝗴𝗲𝘁. 💜 Today, 19 May, is World 𝗜𝗕𝗗 𝗗𝗮𝘆. Inflammatory Bowel Disease, which includes Crohn’s disease and ulcerative colitis, affects around 10 million people worldwide. It flares and quiets, and even when symptoms ease, inflammation can still be present underneath. That is what makes it easy to dismiss, and easy to delay acting on. So a simple message today. If your body has been telling you something, whether it is persistent abdominal pain, changes in your gut, or fatigue that doesn’t lift, listen to it.  Book the check-up.  Ask the question.  Whether it turns out to be IBD or something else entirely, knowing is always better than wondering. 𝘊𝘢𝘵𝘤𝘩𝘪𝘯𝘨 𝘵𝘩𝘪𝘯𝘨𝘴 𝘦𝘢𝘳𝘭𝘺 𝘪𝘴 𝘬𝘪𝘯𝘥𝘦𝘳 𝘵𝘩𝘢𝘯 𝘤𝘢𝘵𝘤𝘩𝘪𝘯𝘨 𝘵𝘩𝘦𝘮 𝘭𝘢𝘵𝘦. And if today is the first time you’re hearing about IBD, the kindest thing you can do is pass this on. Someone in your network may have been waiting for a reason to make that call. Special thanks to Mira Manck for sharing the image. I was looking around for something that fit today, and this one landed exactly right. 🥑💜 #WorldIBDDay2026 #IBDAwareness #WeAreAbbVie

Ilmoittaudu ja opi tärkein migreenistä työelämässä

Migreeni maksaa Suomelle yli 700 miljoonaa euroa vuodessa. Merkittävä osa kustannuksista syntyy työelämässä. Parempi tunnistaminen ja tuki voisivat hyödyttää sekä sairastavia että työpaikkoja.

www.abbvie.com/ Abb Vie Inc - Meet Our Leadership Team A Research-Driven Biopharmaceutical Company. See How Abb Vie Go Beyond Treating Diseases. Find Press Releases, News and Media Statements About...

www.abbvie.com/ Abb Vie Inc. - Our Culture & History Find The Company's Mission, Principles & Culture. See What We Do Beyond Treating Diseases. See What Abb Vie Does To Make An Impact On...

Se’ www.abbvie.com/ Abb Vie Inc. - Advancing Patient Health Find The Company's Mission, Principles & Culture. See What We Do Beyond Treating Diseases. See What Abb Vie Does To Make An Impact On Patients’ Lives. Learn About What We Care About. Our Science & Studies. Our Strategy.

www.abbvie.com/ Abb Vie Inc. - Advancing Patient Health Find The Company's Mission, Principles & Culture. See What We Do Beyond Treating Diseases. See What Abb Vie Does To Make An Impact On Patients’ Lives. Investor Resources Find Financial Reports, Stock Info And More Resources For Investors. Supporting Our Workforce Embracing Equality & Diversity Makes Us More Innovative. Read Abb Vie Stories Abb Vie News Center

www.abbvie.com/ Abb Vie Inc - Meet Our Leadership Team A Research-Driven Biopharmaceutical Company. See How Abb Vie Go Beyond Treating Diseases. See What Abb Vie Does To Make An Impact On Patients’ Lives. See Our Mission & Principles.

www.abbvie.com/ Abb Vie Inc. - Meet Our Leadership Team A Research-Driven Biopharmaceutical Company. See How Abb Vie Go Beyond Treating Diseases. Abb Vie News Center ( Read Abbv Vi

www.abbvie.com/ Abb Vie Inc - Our Culture & History Find The Company's Mission, Principles & Culture. See What We Do Beyond Treating Diseases. See What... Read Abb Vie Stories Read Stories About Our Science, People, and More Today. Supporting Our Workforce Embracing Equality & Diversity Makes Us More Innovative. Our Science See How We Impact Lives. More Than Developing Medicines.

www.abbvie.com/ Abb Vie Inc. - Abb Vie Inc. Leadership Team A Research-Driven Biopharmaceutical Company. See How Abb Vie Go Beyond Treating Diseases.